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Abstract: Principal component analysis (PCA) multivariate analysis was applied to study the
cytotoxic activity of essential oils from various species of the Pistacia genus on human tumor cell
lines. In particular, the cytotoxic activity of essential oils obtained from P. lentiscus, P. lentiscus
var. chia (mastic gum), P. terebinthus, P. vera, and P. integerrima, was screened on three human
adenocarcinoma cell lines: MCF-7 (breast), 2008 (ovarian), and LoVo (colon). The results indicate
that all the Pistacia phytocomplexes, with the exception of mastic gum oil, induce cytotoxic effects on
one or more of the three cell lines. PCA highlighted the presence of different cooperating clusters
of bioactive molecules. Cluster variability among species, and even within the same species, could
explain some of the differences seen among samples suggesting the presence of both common
and species-specific mechanisms. Single molecules from one of the most significant clusters were
tested, but only bornyl-acetate presented cytotoxic activity, although at much higher concentrations
(IC50 = 138.5 µg/mL) than those present in the essential oils, indicating that understanding of the full
biological effect requires a holistic vision of the phytocomplexes with all its constituents.
Keywords: Pistacia; terpenes; cytotoxic; principal component analysis
1. Introduction
Herbal medicine is emerging as a holistic tool in novel personalized medicine approaches,
especially in primary and secondary prevention [1]. In addition to being a primary source of drugs,
phytocomplexes, thanks to their multiple active components, can represent effective strategies to
integrate pharmacological therapies or, like in Traditional Chinese Medicine, be themselves therapeutic
multitarget agents [2,3].
Plants are a major source of chemopreventive phytochemicals [4]. Among these molecules, some
terpenes have been shown to exert cytotoxic activity on tumoral cells in different in vitro, in vivo,
and clinical studies [5–9]. D-Limonene, one of the most widespread natural monoterpenes, exerts
in vitro anti-tumor activity against several cancer types: neuroblastoma, leukemia, breast, skin, liver,
lung, and stomach cancer [10–15]. Similarly, other dietary monoterpenes, like geraniol, carvacrol,
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thymol, eugenol, p-cymene, 1,4-terpineol, α-terpinene, α-copaene, α-elemene, α-humulene, and
α-caryophyllene, among others, have shown significant cytotoxic activity in different cancer cell
lines [8,15–21].
Pistacia, a genus of flowering plants from the family Anacardacee, includes several species largely
distributed and rich in terpenoids [7,22], which represent a large portion of their essential oils. The
Pistacia genus comprises more than twenty species and, among them, P. lentiscus, P. terebinthus, P. vera,
P. integerrima, and P. lentiscus L. var. chia are more popular and have been extensively used in traditional
medicine for their tonic, antiseptic, antihypertensive, and gastro-protective properties [7,22,23].
More recently, different pharmacological activities, including antioxidant, antimicrobial, antidiabetic,
anti-inflammatory, and antitumor activities have been reported [7].
Most published data are related to the resin of P. lentiscus L. var. chia (known as mastic gum) which
has been reported to exert cytotoxic activity on tumor cells and inhibition of cancer cell proliferation,
angiogenesis, and inflammatory response [7,24–31].
A number of studies concerning the cytotoxic activity of other Pistacia species have been carried
out, mostly using extracts and not terpenes-rich essential oils [7,32–38]. In some cases, essential oils
were shown to possess cytotoxic activity on different tumor cell lines [36,39]. In the present study,
we first screened the cytotoxic potential of different essential oils from several species (P. lentiscus,
P. lentiscus L. var. chia, P. terebinthus, P. integerrima, and P. vera) on three human adenocarcinoma cell
lines: MCF-7 (breast), 2008 (ovarian), and LoVo (colon). A multivariate analysis approach was then
used to investigate the statistical correlations among the different phytocomplex components of the
essential oils, allowing the identification of clusters of molecules cooperating in the cytotoxic activity.
2. Results and Discussion
2.1. Chemical Analysis of Essential Oils
Essential oils were obtained by hydrodistillation of aerial parts of the plants, or obtained from
producers, and oil composition was determined using GC-MS. Tables 1 and 2 show the main
components of oil samples from P. lentiscus L. (including P. lentiscus L., var. chia), P. terebinthus
L., P. vera L., and P. integerrima J.L. Stewart ex Brandis, as identified by the Wiley mass spectra library.
A total of 32 samples from different aerial parts of the plants were analysed. Although most terpenes
were present in both P. lentiscus and P. terebinthus samples, the oil composition varied considerably,
with limonene and cis-ocimene being more meaningfully present in samples from P. terebinthus, while
β-phellandrene, 1,4- and α-terpineol, α- and γ-terpinene, and T and α-cadinol were relatively more
abundant in samples from P. lentiscus. Collectively, the two species show similar amounts of α- and
β-pinene, β-caryophyllene, and butylated hydroxy toluene. Among the samples from other species,
those from P. integerrima showed similarities to P. terebinthus in the content of α- and β-pinene and of
β-caryophyllene, and to P. lentiscus in the amounts of 1,4- and α-terpineol, endoborneol, and bornyl
acetate. Finally, a significant amount of δ-carene appears to be characteristic of all the three species. Oil
samples from P. lentiscus var. chia (resin) and from P. vera (nuts) are the ones with the least similarities
with the others. The composition of the essential oils indicates consistency with the major terpenes
known to be present in these species [7].
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Table 1. Oil composition of P. lentiscus, P. lentiscus var. chia, P. vera, and P. integerrima.
RT Oil Composition
P. lentiscus var. chia P. vera P. integerrima
A (l) B (l) C (l) D (l) E (l) F (l) G (be) H (be) I (be) J (br) K (br) L (r) M (n) N (g) O (g)
6.08 Tricyclene - 0.33 0.58 0.14 0.06 1.20 - - - 0.90 - - - - -
6.22 α-Phellandrene - 1.51 0.12 0.14 0.20 0.15 0.61 - 0.20 - 0.14 - - - -
6.48 α-Pinene 12.95 11.45 12.97 9.17 24.68 12.86 20.13 6.11 40.68 18.15 13.73 72.93 0.99 14.41 22.37
6.94 Camphene 2.05 1.46 2.49 0.52 0.58 4.96 1.06 - 0.98 3.90 0.22 0.58 - 0.94 1.32
7.78 Sabinene 1.16 4.31 4.56 2.87 2.32 4.47 0.99 1.21 0.86 2.83 6.77 0.30 - 2.51 2.46
7.88 β-Pinene 4.33 3.07 4.38 1.15 8.64 4.25 4.13 0.48 7.60 4.19 0.94 2.58 - 5.62 7.63
8.40 β-Myrcene 8.42 0.97 0.67 4.45 0.91 9.23 23.80 57.79 1.08 4.08 5.47 13.57 - 2.81 3.20
8.86 1-Phellandrene 0.69 4.64 0.80 4.60 2.12 2.07 3.84 3.79 0.92 0.81 8.35 - - 0.56 0.77
9.02 Methylanisol - - - - - - - - - - - 0.58 - - -
9.07 δ-Carene 0.67 - - - - - - - - 3.14 - - - 4.06 8.36
9.33 α-Terpinene 0.56 4.66 3.60 3.76 3.11 2.82 2.71 0.90 1.13 0.72 1.73 - - 0.80 1.80
9.69 para-Cymene 6.43 0.64 0.22 0.50 0.35 0.30 0.48 0.34 0.16 0.42 0.98 - - 2.09 3.72
9.81 β-Phellandrene - 6.48 4.93 5.79 11.35 4.73 6.48 3.44 8.03 - 6.61 - - - -
9.89 Limonene 17.55 - - - - - - - - - - 0.89 1.54 5.94 7.81
10.21 cis-Ocimene - 0.60 0.35 1.00 0.72 0.52 - 0.29 0.22 1.08 0.61 - - - -
10.62 Trans-β-Ocimene 0.14 0.41 0.23 0.53 0.46 0.35 - 0.57 - 0.32 0.23 - - - -
10.96 Butanoic Acid - - - - 0.55 - - - 1.07 - - - - - -
11.03 γ-Terpinene 1.24 7.42 5.90 6.11 4.89 4.94 4.93 1.85 2.24 1.51 2.96 - - 1.52 3.74
12.26 α-Terpinolene 0.61 2.48 2.08 2.35 2.59 1.75 2.08 0.63 2.27 0.64 1.04 - - 0.57 1.61
12.49 2-Nonanone - 0.34 0.17 0.19 0.63 0.30 0.44 0.31 1.65 - - - - - -
12.60 α-Pinene Oxide - - - - - - - - - - - 0.56 - - -
12.74 Linalool 0.11 - 0.15 0.22 0.39 - - - - - 0.36 0.73 - - -
12.96 Pinocarveol - - - - - - - - - - - 0.21 - - -
14.64 Pinocarvone - - - - - - - - - - - 0.10 - - -
14.70 Camphor 0.13 - - - 0.08 0.31 - - - - - - - - -
15.74 Endoborneol 6.77 0.12 0.34 - 0.24 0.43 0.32 - 0.65 - - - - 3.12 1.02
16.20 1-4 Terpineol 3.37 14.89 12.26 13.11 7.12 10.43 8.78 4.09 2.63 3.03 6.98 - 2.13 29.52 20.69
16.79 α-Terpineol 0.78 4.92 5.36 6.42 7.41 4.96 7.97 1.11 9.83 1.41 1.13 - 2.56 14.08 8.74
17.48 Myrtenol - - - - - - - - - - - 0.18 - - -
19.44 Octanoid Acid - 0.18 0.13 0.22 - 0.19 - - 0.54 - 0.17 - - - -
21.04 Bornyl Acetate 24.48 2.12 1.77 0.17 - 0.52 1.94 - - 0.98 0.28 - - 4.55 1.55
21.39 Verbenone - - - - - - - - - - - 0.26 - - -
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Table 1. Cont.
RT Oil Composition
P. lentiscus var. chia P. vera P. integerrima
A (l) B (l) C (l) D (l) E (l) F (l) G (be) H (be) I (be) J (br) K (br) L (r) M (n) N (g) O (g)
21.42 2-Undecanone 0.30 0.69 0.19 0.55 0.99 0.67 0.41 0.59 1.38 1.47 0.65 - - - -
24.77 α-Ylangene - 0.42 0.87 0.70 - 0.30 - 0.32 - 0.46 0.60 - - - -
25.39 β-Cubebene - - 0.25 0.21 - - - - - - 0.34 - - - -
25.47 β-Elemene - 0.15 0.19 0.23 0.11 0.16 - - - 0.52 0.51 - - - -
26.61 β-Caryophyllene 2.09 2.79 3.21 3.24 4.02 4.92 0.44 0.81 1.18 3.91 1.70 0.30 0.60 2.81 1.96
27.85 α-Cubebene - - 0.05 0.24 - - - - - - - - - - -
27.96 α-Humulene 0.17 1.02 0.88 1.13 0.48 1.09 0.25 0.37 - 1.10 0.60 - - - -
28.25 Alloaromandrene 0.10 0.30 0.34 0.39 - 0.24 - - - 0.44 0.48 - - - -
28.99 α-Amorphene 0.37 0.85 1.51 1.30 0.17 0.64 0.35 0.80 0.39 1.16 1.13 - - - -
29.10 Germacrene D 0.25 4.71 6.82 5.00 1.37 4.34 2.06 2.76 1.23 8.36 8.32 - 0.62 - -
29.66 α-Elemene - 0.33 0.41 0.51 0.26 0.34 - - 0.35 0.90 0.99 - - - -
29.89 α-Muurolene 0.13 0.71 1.21 1.07 0.33 0.68 - 0.68 0.44 0.98 0.93 - - - -
30.05 Germacrene A - 0.14 0.18 0.30 0.16 0.23 - - - 0.44 0.68 - - - -
30.42 Butylated Hydroxy Toluene - 0.60 0.81 1.36 0.44 1.14 0.88 1.23 1.72 4.33 1.25 - 15.74 - -
30.81 δ-Cadinene 0.20 2.82 4.80 4.40 1.11 2.52 1.32 3.28 1.74 4.44 3.99 - 0.66 - -
32.26 Spathulenol - - - - - - - - - - - - - 1.26 0.53
32.78 γ-Cadinene 0.54 - - - - - - - - 0.19 0.87 - - - -
33.20 Caryophyllene Oxide 2.53 - - - 0.12 - - - - 0.83 - - - - -
34.79 Cadina-1,4-Diene - 0.83 1.26 1.50 0.20 0.61 - 0.46 - 0.86 0.71 - - - -
34.92 γ-Eudesmol - 1.21 0.96 1.07 0.48 0.77 0.41 0.63 0.28 - 0.61 - - - -
35.31 α-Cadinol - 2.50 3.29 4.13 1.63 2.52 0.76 1.96 0.97 3.18 2.70 - - - -
35.45 α-Copaene - 0.75 1.03 1.29 0.49 0.76 - 0.53 0.31 1.22 0.81 - - - -
35.58 β-Eudesmol - 0.47 0.31 0.41 0.19 0.28 - - 0.20 - 0.46 - - - -
35.80 T-Cadinolo 0.85 3.16 3.90 4.73 2.61 3.55 1.15 2.79 1.68 4.53 3.77 - - - -
56.28 Nonadecane - - - - - - - - - - - - - - -
61.56 Octadecane - - - - - - - - - - - - - - -
67.79 CPA 1 - - - - - - - - - - - - 32.88 - -
67.96 Benzene1Methox 2 - - - - - - - - - - - - 25.63 - -
69.78 4,12BisHydroxy 3 - - - - - - - - - - - - 4.29 - -
Different Essential Oil samples were identified progressively using letters from A–O. (l) leaves, (be) berries, (br) branches, (f) flowers, (r) resin, (n) nuts, (g) galls.
RT: retention time. Values are percent of the total oil composition. 1 4-chloro-2-phenylaniline. 2 Benzene-methoxy-trimethyl-tetrahydro-halenedica-urs-12-en-28-al;
3 4,12-bis(hydroxymethyl)-2,2-metac-4,14-bis(hydroxymethyl)-2,2-metac-1-oxo-2,3,5,6,7,8-hexahydrothienol.
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Table 2. Oil composition of P. terebinthus.
RT Oil Composition P (l) Q (l) R (l) S (l) T (l) U (l) V (l) W (l) X (l) Y (be) Z (be) AA (g) AB (g) AC (f) AD (f) AE (f) AF (br)
6.08 Tricyclene - - - - - 0.25 - - - 0.30 - - - 0.48 0.45 - 0.18
6.22 α-Phellandrene - - - - - - - - - - - - - 0.21 - - 0.36
6.48 α-Pinene 35.6 12.17 41.03 11.61 14.1 60.9 10.0 10.99 18.7 31.63 8.69 54.19 42.16 28.90 26.43 11.74 28.72
6.94 Camphene 0.55 0.26 1.02 - - 1.56 0.24 0.37 0.46 1.50 0.48 0.69 0.67 2.12 1.83 - 1.06
7.78 Sabinene - 0.62 - 0.39 - 0.22 0.15 0.28 - 1.20 0.85 0.65 0.18 2.00 0.91 1.41 4.53
7.88 β-Pinene 1.12 1.14 6.17 1.39 0.71 1.87 0.32 1.48 3.27 7.44 1.39 3.68 1.81 6.40 5.85 2.12 4.07
8.40 β-Myrcene 1.57 1.68 1.37 1.82 2.03 1.98 1.41 1.60 2.90 1.21 1.11 1.05 1.42 1.68 0.97 31.56 1.67
8.86 1-Phellandrene 0.62 0.35 0.49 0.75 0.62 0.47 0.19 0.29 0.27 3.34 7.66 0.49 6.61 0.32 0.37 0.61 0.59
9.02 Methylanisol - - - - - - - - - - - - - - - - -
9.07 δ-Carene - - - 1.23 - 0.76 - - - - - - - - - - -
9.33 α-Terpinene - 0.43 0.83 0.71 - 0.44 - 0.21 0.34 0.25 0.34 - - 0.65 0.51 - 1.46
9.69 Para Cymene - 0.11 - - - 0.17 - - - 0.38 - - 0.18 0.20 - 0.79 0.49
9.81 β-Phellandrene - - - - - - - - - - - - - - - - -
9.89 Limonene 27.4 50.70 6.09 21.04 60.4 6.16 1.23 8.03 60.2 12.59 32.85 13.97 31.07 28.76 23.03 5.58 6.56
10.21 Cis-Ocimene 19.6 15.64 10.93 20.97 3.86 6.31 63.6 54.19 0.96 6.79 17.99 1.89 0.37 - 3.88 - 13.44
10.62 Transβ-Ocimene 5.49 4.45 3.80 6.04 1.17 1.86 18.3 16.46 0.38 1.66 5.01 0.40 - - 1.22 - 3.33
10.96 Butanoic Acid - - - - - - - - - - - - - - - - -
11.03 γ-Terpinene 0.22 0.69 0.48 0.62 - 0.49 0.17 0.34 0.60 0.33 0.42 0.12 - 1.08 0.77 0.46 2.46
12.26 α-Terpinolene 0.92 0.93 17.07 16.59 4.90 7.13 0.38 0.46 1.76 0.44 1.27 0.26 0.28 0.57 2.99 - 1.08
12.49 2-Nonanone - - - - - - - - - - - - - - - - -
12.60 α-Pinene Oxide - - - - - - - - - - - - - - - - -
12.80 Linalool - - - - - 0.18 - - - - 0.17 - - - - - -
12.96 Pinocarveol - - - - - - - - - - - - - - - - -
14.64 Pinocarvone - - - - - - - - - - - - - - - - -
14.70 Camphor - - - - - - - - - - - - - - - - -
15.74 Endoborneol - - - - - - - - - - - - - - - - -
16.20 1-4 Terpineol 0.31 1.63 0.29 1.86 1.21 0.29 0.35 0.50 0.46 1.00 0.87 0.18 0.13 2.86 1.55 - 8.91
16.79 α-Terpineol 1.63 4.05 5.22 1.92 1.18 2.23 1.35 1.22 2.87 2.43 0.93 0.35 1.36 1.69 1.45 - 2.26
17.48 Myrtenol - - - - - - - - - - - - - - - - -
19.44 Octanoid Acid - - - - - - - - - - - - - - - - -
21.04 Bornyl Acetate - - 0.47 - - - - - - 0.64 0.35 - 0.18 - - - 0.23
21.39 Verbenone - - - - - - - - - - - - - - - - -
21.42 2-Undecanone - - - - - - - - - - - - - - - - -
24.77 α-Ylangene 0.23 0.16 - - - - - - - 4.51 0.96 0.15 0.19 - 2.14 - 0.51
25.39 β-Cubebene - - - - - - - - - 1.60 0.40 - - - 0.37 - 0.19
25.47 β-Elemene - - - - - - - - - - - - - - - - -
26.61 β-Caryophyllene 3.23 1.38 2.75 4.72 2.00 3.86 0.62 1.29 3.43 4.77 1.64 14.33 0.94 0.97 8.05 0.63 1.06
27.85 α-Cubebene - - - - - - - - - 0.26 0.42 - - - - - 0.74
27.96 α-Humulene 0.47 0.33 - 0.86 1.07 1.21 - - 1.46 1.47 0.55 2.15 0.33 0.65 1.24 - 0.22
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Table 2. Cont.
RT Oil Composition P (l) Q (l) R (l) S (l) T (l) U (l) V (l) W (l) X (l) Y (be) Z (be) AA (g) AB (g) AC (f) AD (f) AE (f) AF (br)
28.25 Alloaromandrene - - - - - - - - - - - - - - - - -
28.99 α-Amorphene - 0.24 - - - - 0.17 - 0.30 0.55 0.24 - 0.15 0.43 0.48 1.27 0.77
29.10 Germacrene D 0.23 0.62 - 1.56 1.40 - 0.14 0.45 - 2.24 9.42 2.91 7.08 5.87 2.44 4.45 2.91
29.66 α-Elemene - - - - - - - - - 0.18 - - - - - - 0.46
29.89 α-Muurolene - - - - - - - - - 0.25 - - - 0.33 0.27 0.76 0.47
30.05 Germacrene A - - - - - - - - - - - - 0.14 - - - -
30.42 Butylated Hydroxy Toluene 0.32 0.77 0.37 3.34 2.36 0.62 0.46 0.45 0.55 0.58 0.46 0.30 0.45 1.56 1.58 - 1.82
30.81 δ-Cadinene 0.44 0.67 - 1.32 0.92 0.31 0.31 0.63 0.61 6.42 2.33 0.31 0.55 1.22 3.61 3.06 3.51
32.26 Spathulenol - - - - - - - - - - - - - - - - -
32.78 γ-Cadinene - - - - - - - - - - - - - - - 0.84 -
33.20 Caryophyllene Oxide - 0.23 - - - 0.27 - - - 0.40 - 0.39 - - 0.75 - -
34.79 Cadina-1,4-Diene - - - - - - - - - 0.31 0.17 - - - 0.36 - 0.31
34.92 γ-Eudesmol - - - - - - - - - - - - 0.70 - - - -
35.31 α-Cadinol - - - - - - - - - 0.26 - - 0.21 0.81 0.73 - 0.53
35.45 α-Copaene - - - - - - - - - 0.39 0.55 - - 0.25 0.19 - -
35.58 β-Eudesmol - - - - - - - - - - - - 0.21 - - - -
35.80 T-Cadinolo - 0.17 - - - - - - - 0.31 0.65 - 0.30 1.14 0.87 1.26 0.36
56.28 Nonadecane - - - - - - - - - - - - - 2.20 1.04 - -
61.56 Octadecane - - - 0.47 - - - - 0.25 - - - - 1.99 0.71 - -
67.79 CPA 1 - - - - - - - - - - - - - - - - -
67.96 Benzene1Methox 2 - - - - - - - - - - - - - - - - -
69.78 4,12BisHydroxy 3 - - - - - - - - - - - - - - - - -
Different Essential Oil samples were identified progressively using letters from P–Z and AA–AF. (l) leaves, (be) berries, (br) branches, (f) flowers, (r) resin, (g) galls.
RT: retention time. Values are percent of the total oil composition. 1 4-chloro-2-phenylaniline. 2 Benzene-methoxy-trimethyl-tetrahydro-halenedica-urs-12-en-28-al; 3
4,12-bis(hydroxymethyl)-2,2-metac-4,14-bis(hydroxymethyl)-2,2-metac-1-oxo-2,3,5,6,7,8-hexahydrothienol.
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2.2. Cytotoxic Activity of Essential Oils on Human Tumor Cell Lines
The cytotoxic activity of the phytocomplexes from the different Pistacia species was evaluated
in vitro on three human adenocarcinoma cell lines: MCF-7 (breast adenocarcinoma); 2008 (ovarian
adenocarcinoma); and LoVo (colon adenocarcinoma). Results are shown in Table 3.
Most oil samples displayed some cytotoxic activity on one or more cell lines with different
potencies. In particular, looking at the results obtained with LoVo cells, all the samples from P. lentiscus
were active, with the exception of the one from P. lentiscus var. chia. Samples from P. terebinthus
displayed a high frequency of activity, above 70%, while both samples from P. integerrima were active
and the one from P. vera was not. The sample with the most activity was one essential oil from P.
lentiscus leaves (sample A: IC50 = 173.9 µg/mL).
Apart from P. lentiscus on LoVo cells, none of the species was active on all the other cell lines. In
particular the activity towards 2008 cells was higher for the samples from P. terebinthus (71%), while P.
lentiscus displayed a significant activity in 55% of samples, while the two samples from P. integerrima
were active and those from P. vera and P. lentiscus var. chia were not. The two most active samples
were both from P. lentiscus leaves (sample A: IC50 = 181.5 µg/mL and sample C: IC50 = 220.4 µg/mL).
The activity on MCF-7 cells was higher for the samples from P. lentiscus (73%), and it was the only
cell line sensitive to the essential oil from P. vera. Essential oils from P. terebinthus were active in 44% of
cases, while the two oils from P. integerrima had a weak effect or were inactive. The two most active
samples were from P. lentiscus leaves (sample B: IC50 = 239.6 µg/mL), from P. terebinthus galls (sample
AB: IC50 = 254.9 µg/mL) and from P. vera nuts (sample A3: IC50 = 290.6 µg/mL).
Taken together the results indicate a dose dependent cytotoxic effect of different Pistacia species
phytocomplexes on all the three cell lines tested, in most cases with IC50 values below 500 µg/mL,
suggesting that this effect might be a shared feature of the Pistacia genus. There were wide differences
in biological activity between samples, regardless of the species and even the anatomical part, likely
related to the high variability in oil composition even within the same species, as determined by
GC/MS fingerprinting.
The oils did not show a consistent order of potency from one cell line to the other, and in some case
the same sample could display high activity on one cell line, while being inactive on the others (Table 3).
Such different sensitivity of the three cell lines to the same oils suggests that the cytotoxicity mediating
network of molecular targets (from receptors, to second messengers to DNA expression regulators) is
not the same in the three cell lines, which then respond in a different fashion to the multiple bioactive
compounds present in the phytocomplexes. This aspect is pharmacologically relevant and suggests
cell lines’ specific effects.
In general, the biological activity of a phytocomplex is related to its chemical composition, with
each single compound acting synergistically with the others. Thus, given the high heterogeneous
compositions of essential oils, likely due to genetic diversity of the samples [40], it is difficult to define
a unique mechanism of action and indeed, a molecule, or a cluster of molecules, could have an effect
on one type of tumor and not on others [9], determining important differences even in essential oils
from the same species [41].
Terpenes and terpene-rich essential oils have been shown to exert specific cytotoxic activity
on several tumoral cell lines [9,42–45]. Cytotoxic activity on tumoral cell lines has been previously
identified in plants from the Pistacia genus, but most studies have focused on different types of extracts
and not on the terpene-rich essential oils, suggesting other types of chemicals and mechanisms were
involved [7,32,34,38]. In some cases essential oils from Pistacia species have been shown to exert
cytotoxic activity on tumoral cell lines. Pistacia vera and Pistacia khinjuk resin essential oils were found
to be active against retinoblastoma cells (Y79) [36]. Essential oil from P. palestina Boiss. Although
inactive on MCF-7 cells, displayed cytotoxic activity towards amelanotic melanoma cells (C32) and
renal cell adenocarcinoma (ACHN) [39]. Our results are, thus, consistent with previous observations on
the same genus. A significant amount of data has been produced on the cytotoxic, or antiproliferative
effect of P. lentiscus var. chia, although in most cases not with essential oil [7,30,31]. In some cases
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essential oil from the resin was used and a significant cytotoxic effect was observed [24,26]. Although
we used the same type of essential oil from P. lentiscus var. chia resin (mastic), we did not observe any
cytotoxic activity in our experimental conditions. This discrepancy could be related to the different
experimental models used, to the different treatment with the essential oil, or to the relatively stringent
threshold we used for the cytotoxic effectiveness (500 µg/mL). To eliminate nonspecific interferences
with adhesion of cells to the experimental substrate, a “pre-incubation” strategy was also used. Unlike
the other published data, cell cultures were exposed to essential oils only for three hours and then
allowed to recover for the following 21 h. The limitation of unwanted effects on cell adhesion, by
improving the focus on cytotoxicity, might explain the different results.
Table 3. Cytotoxic effect of Pistacia essential oils.
Samples LoVo Cells 2008 Cells MCF-7 Cells
A
173.9 (151.0–200.3) µg/mL 181.5 (166.5–197.7) µg/mL 249.4 (243.5–255.4) µg/mL
n = 3 n = 7 n = 3
B
410.8 (302.4–558.1) µg/mL >600 µg/mL 239.6 (189.3–303.3) µg/mL
n = 2 n = 2 n = 2
C
399.3 (349.6–456.1) µg/mL 220.4 (107.0–454.2) µg/mL 543.1 (503.6–585.7) µg/mL
n = 2 n = 3 n = 1
D
420.0 (335.7–525.6) µg/mL 395.0 (310.8–502.1) µg/mL 591.4 (272.7–1283) µg/mL
n = 5 n = 4 n = 2
E
401.3 (323.5–497.8) µg/mL >600 µg/mL 499.4 (447.9–556.9) µg/mL
n = 4 n = 5 n = 2
F
461.6 (273.1–780.2) µg/mL N.A. >600 µg/mL
n = 3 n = 2 n = 1
G
438.3 (309.0–621.6) µg/mL 515.9 (435.1–611.6) µg/mL N.A.
n = 2 n = 3 n = 2
H
414.4 (362.9–473.3) µg/mL N.A. N.A.
n = 2 n = 2 n = 3
I
539.3 (475.0–612.3) µg/mL N.A. 299.9 (260.4–345.4) µg/mL
n = 3 n = 1 n = 2
J
369.1 (334.1–407.7) µg/mL 388.0 (334.5–450.1) µg/mL 356.1 (295.1–429.7) µg/mL
n = 2 n = 2 n = 3
K
417.7 (392.1–445.1) µg/mL 312.1 (140.6–692.7) µg/mL 311.6 (260.4–373.0) µg/mL
n = 2 n = 2 n = 2
L
N.A. N.A. N.A.
n = 3 n = 3 n = 3
M
N.A. N.A. 290.6 (210.2–401.8) µg/mL
n = 2 n = 1 n = 3
N
444.7 (418.3–472.8) µg/mL 359.0 (328.1–392.9) µg/mL N.A.
n = 3 n = 2 n = 3
O
511.2 (427.6–611.2) µg/mL 556.1 (512.2–603.7) µg/mL 515.0 (407.2–651.5) µg/mL
n = 3 n = 2 n = 2
P
403.1 (255.9–635.0) µg/mL 401.5 (334.7–481.5) µg/mL N.A.
n = 2 n = 3 n = 4
Q
473.4 (418.8–535.1) µg/mL N.A. N.A.
n = 2 n = 1 n = 1
R
464.4 (421.9–511.3) µg/mL 464.1 (384.0–560.9) µg/mL 501.2 (429.6–584.7) µg/mL
n = 2 n = 2 n = 2
S
427.6 (411.7–444.2) µg/mL 337.6 (243.8–467.4) µg/mL N.A.
n = 2 n = 1 n = 3
T
425.9 (395.2–458.9) µg/mL 325.0 (238.9–442.1) µg/mL 392.0 (357.1–430.4) µg/mL
n = 2 n = 2 n = 3
U
406.7 (367.2–450.4) µg/mL 348.1 (263.7–459.5) µg/mL N.A.
n = 3 n = 2 n = 3
V
400.4 (270.0–593.6) µg/mL 398.0 (367.0–431.6) µg/mL N.A.
n = 2 n = 2 n = 3
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Table 3. Cont.
Samples LoVo Cells 2008 Cells MCF-7 Cells
W
N.A. 371.6 (291.9–472.9) µg/mL N.A.
n = 2 n = 2 n = 3
X
392.1 (310.7–494.8) µg/mL 484.0 (387.2–604.9) µg/mL 572.6 (424.8–771.8) µg/mL
n = 2 n = 3 n = 2
Y
509.8 (377.6–688.3) µg/mL 598.6 (557.5–642.8) µg/mL N.A.
n = 2 n = 6 n = 4
Z
411.8 (276.4–613.6) µg/mL 453.2 (403.7–508.7) µg/mL 512.9 (323.6–812.9) µg/mL
n = 2 n = 2 n = 2
AA
>600 µg/mL 591.9 (509.2–688.0) µg/mL 503.3 (470.9–537.9) µg/mL
n = 2 n = 3 n = 1
AB
N.A. N.A. 254.9 (243.3–267.1) µg/mL
n = 2 n = 1 n = 2
AC
441.0 (404.4–481.0) µg/mL N.A. 297.7 (277.6–319.2) µg/mL
n = 3 n = 2 n = 3
AD
345.2 (297.8–400.1) µg/mL N.A. N.A.
n = 2 n = 1 n = 1
AE
>600 µg/mL 331.4 (266.9–411.5) µg/mL >600 µg/mL
n = 1 n = 1 n = 1
AF
405.6 (355.5–462.7) µg/mL N.A. N.A.
n = 4 n = 1 n = 1
CisPlatin 10.7 (7.1–17.9) µg/mL 4.1 (2.6–7.2) µg/mL 45.0 (25.9–71.7) µg/mL
n = 3 n = 3 n = 3
Different Essential Oil samples were identified progressively using letters from A–Z and AA–AF. Values are means
(confidence interval). N.A. (not active).
2.3. Principal Component Analysis of the Bioactive Essential Oils
PCA analysis was performed with the aim of identifying synergic clusters of compounds present
in the phytocomplexes, with the best correlation with biological activity (Figures 1–3 and Table 4).
Four principal components were used (PC1, PC2, PC3, and PC4) which together accounted for more
than 60% of the total variance in all three cell lines (Table 4). Positive correlations with one or more
principal components were identified for each cell line and each active species in the PC biplot. The
highest percent value of association with bioactivity was chosen, proceeding down from the strongest
association, until a cluster of active molecules could be identified. PCA allowed the identification of
18 clusters of putative bioactive compounds (compounds likely to cooperate in the cytotoxic activity),
many of them differing among cell lines for just one or a few compounds (Table 5). MCF-7 was the cell
line with more clusters of bioactive compounds (n = 7), while LoVo and 2008 cells had six and five,
respectively. All the compounds showing a high level of correlation with bioactivity were included
at least in one cluster, with the exception of sabinene and α-humulene, the latter a known anticancer
agent [18]. P. lentiscus was the species with more clusters of bioactivity-associated molecules in all
cell lines. P. lentiscus was also the species with higher principal component scores, with L2 being the
cluster with the highest values (43.2% LoVo, 42.5% 2008, 44.9 MCF-7).
The active cluster identified for P. integerrima on LoVo cells (I1: spathulenol, endoborneol,
p-cymene, bornyl acetate) is also the core part of I1a and I1b and correlates with activity in all
cell lines and, is shared by all L1s P. lentiscus clusters, thus suggesting a common mechanism of P.
lentiscus and P. integerrima phytocomplexes throughout the cell lines. Although the aim of the work
was not to identify biological activity in single terpenes, given that this particular cluster is shared by
all cell lines and at the same time by more than one Pistacia species, we tested the cytotoxic activity of
the pure compounds on LoVo cells, where the activity of the phytocomplexes seemed to be stronger.
Bornyl acetate was the only tested molecule showing a cytotoxic activity when used alone (IC50 =
138.5 (130.8 to 146.7 µg/mL), although its potency was not as strong as that corresponding to the
actual concentration range in the oils. The other compounds displayed no activity in the pre-treatment
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paradigm used (data not shown), although p-cymene and spathulenol had been previously shown
to have anti-tumoral activity [15,42]. This points out to the specific biological effect exerted by the
phytocomplex as a whole, which cannot be attributed to a single component but, rather, is likely the
result of a complex network of simultaneous biological signals which contribute to the global cytotoxic
effect. The other cluster whose core compounds are all shared in all the three cell lines is L3 (from P.
lentiscus): α-copaene, α-cadinol, τ-cadinol, cadina-1,4-diene, α-elemene, α-amorphene, germacrene
A, α-muurolene, β-elemene, and alloaromandrene. In this cluster α-copaene and β-elemene are
known cytotoxic compounds for tumoral cells [8,17]. α-Terpinene, α-phellandrene, and α-terpinene
are shared by L2s clusters, although they represent only one third. In this group α-terpinene has been
previously documented for its cytotoxic activity on cancer cells [15,17]. Other active compounds are
associated with bioactivity on all cell lines, but seem not to cooperate consistently with the same clusters.
α-Terpineol and 1-4 terpineol cooperate with cluster L1 and L1a on LoVo and 2008 cells, respectively,
while on MCF-7 cells, though active, cluster with L2b. Both compounds have been previously found
to exert in vitro anti-tumoral activity [15,17]. α-Humulene, another terpene previously shown to be
cytotoxic in vitro [18], is present in clusters of activity in all the three cell lines from both P. lentiscus
and P. terebinthus (L4, T1, T2, T3). Ten more compounds are differentially cooperating in clusters of
cytotoxic activity towards all cell lines, some in the same group, some in totally different contexts
(γ-eudesmol: L2, L2a, L3; sabinene: L2, L2a, S; 2-nonanone: S, L2a, L2b; 2-undecanone: L2, L3a, L2b;
β-eudesmol: L2, L3a, L3b; germacrene D L4, T2, L4a; β-cubebene L4, T1, T2, L4a; α-ylangene: L4, T1,
T2,L4a; δ-cadinene L4, T2, L3b; butylated hydroxytoluene: L4, T1, T2, V1), the last one being the only
clustered molecule shared by P. vera with other species. Other compounds’ bioactivity are not shared
by all three cell lines, thus suggesting a different cell sensitivity and cell-specific mechanisms. Two
such molecules, β-caryophyllene and d-limonene, previously shown to have cytotoxic activity and
considered promising potential anti-tumorals [8,9,15,42,45] are active only on MCF-7 cells as part of
the T3 cluster.
In summary, PCA allowed the identification of 46 compounds in the phytocomplexes correlated
with potential biological activity, most of which had not been previously reported for their in vitro
cytotoxic activity on tumoral cells (80%). The compounds are distributed within different clusters of
molecules potentially cooperating to achieve the cytotoxic activity on the cell lines.
Taken together, the PCA results indicate that the cytotoxic activity of the phytocomplexes can
be highlighted in several clusters of likely-synergizing compounds. P. lentiscus is the species with the
most clusters, which is in line with its higher potency and frequency of activity with respect to the
other species tested. Only two of such clusters are common for all the cell lines, they are characteristic
of P. lentiscus, and one is also shared with P. integerrima. In other cases clusters are shared only for
one or two cell lines. In the case of P. vera, only one cluster could be identified. These similarities and
differences suggest that the cytotoxic effect is complex. Some are common for all three cell lines which
suggests a shared mechanism for all three adenocarcynomas, but some are not and P. lentiscus seems to
display the most variability, while samples from the other species seem more consistent throughout
the different cell lines. This behaviour points to different mechanisms exerted in a cell-specific fashion.
Table 4. Principal component values.
Principal Component LoVo 2008 MCF7
PC1 30.4% 31.1% 33.5%
PC2 12.8% 11.4% 11.4%
PC3 8.8% 10.6% 8.9%
PC4 8.0% 8.9% 8.9%
Total per cell line 60.0% 62.0% 62.7%
Values are percent accountability of the total variance.
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Keeping in mind that the results with PCA do not necessarily explain the full activity of the whole
phytocomplex, the analysis allowed the identification of substances, mostly terpenes, sesquiterpenes,
and fatty acids, present in the essential oils likely playing a central role in the in vitro anti-tumoral effect.
Of these, some had been previously shown to have such activity when used as single compounds.
Almost all the substances identified cooperate with others, thus forming clusters of activity, often
different for one or more components in terms of cell sensitivity.
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blue for P. terebinthus).
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Figure 3. Principal component analysis of the cytotoxic effect of Pistacia essential oils on MCF-7 cells. (A) PCA 
biplot with PC1 and PC2 distribution of essential oil samples and chemical components of the phytocomplexes. 
(B) PCA biplot with PC3 and PC4 distribution of essential oil samples and chemical components of the 
phytocomplexes. Clusters of cooperating compounds with a positive correlation to one or two components are 
identified with circles (green for P. lentiscus, yellow for P. integerrima, blue for P. terebinthus, and red for P. vera).  
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components of the phytocomplexes. Clusters of cooperating compounds with a positive correlation to
one or two components are identified with circles (green for P. lentiscus, yellow for P. integerrima, blue
for P. terebinthus, and red for P. vera).
Table 5. Cluster comparisons.
LoVo 2008 MCF7
Compound
I1 L1 L2 L3 L4 T1 S I1a L1a L2a L3a T2 I1b L1b L2b L3b L4a T3 V1 S
Reported
Cytotoxic Activity
spathulenol [42]
endoborneol
p-cy ene [15]
bornyl acetate
δ-c r ne
α-p ne
β-pi e
α-ter eol [17]
1-4 te ineol [15,46]
cter ene
γ-ter i ene [15,17]
β-phella rene
γ-eudes ol
sabinene
2-nonanone
α-phellandrene
2-undecanone
β-eudesmol
α-copaene [17]
α-cadinol
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Table 5. Cont.
LoVo 2008 MCF7
Compound
I1 L1 L2 L3 L4 T1 S I1a L1a L2a L3a T2 I1b L1b L2b L3b L4a T3 V1 S
Reported
Cytotoxic Activity
T-cadinol
cadina-1,4-diene
β-elemene [8]
α-amorphene
germacrene A
α-muurolene
α-elemene
alloaromandrene
Octanoid acid
germacrene D
α-cubebene
β-cubebene
α-ylangene
1-phellandrene
BHT 1
α-cadinene
tricyclene
α-humulene [18]
trans β-ocimene
cis ocimene
d-limonene [8,15]
β-caryophyllene [8]
BMTTHU 2
HMHMOH 3
CPA 4
camphene
I (integerrima); L (lentiscus); T (terebinthus); V (vera); S = single, unclustered bioactivity-correlated
compounds. 1 Butylated hydroxy toluene; 2 Benzene-methoxy-trimethyl-tetrahydro-halenedica-urs-12-en-28-al;
3 4,12-bis(hydroxymethyl)-2,2-metac-4,14-bis(hydroxymethyl)-2,2-metac-1-oxo-2,3,5,6,7,8-hexahydrothienol;
4 4-chloro-2-phenylaniline.
Finally, although all the compounds identified had a positive correlation with the activity, none of
the single clusters or the single components are, by themselves, sufficient to justify the whole activity,
and at least all the molecules identified contribute to the biological effects.
3. Materials and Methods
3.1. Chemicals
Methanol, ethyl acetate, formic acid, acetonitrile, and HPLC-grade solvents were purchase from
Carlo Erba Reagents Srl (Dasit Group SpA, Cornaredo, Italy). The solvents were of analytical grade.
Double distilled water was used in the HPLC mobile phase. All other reagents, including single
purified terpenes, were obtained from Sigma Aldrich srl. (Milan, Italy).
3.2. Plant Collection
With the exception of P. terebinthus flowers (samples AC, AD, AE) which were collected in
Provence (43◦57′ N 4◦49′ E; Avignon countryside, France), aerial parts (leaves, berries, branches, galls,
nuts) of the plants were collected in three different Italian regions: Pistacia terebinthus L.: Veneto,
Colli Euganei (45◦21′50.01” N 11◦40′13.51” E) (samples P, AB, AF); Pistacia lentiscus L.: Tuscany, San
Giuliano Terme (43◦45′45” N 10◦26′29” E), Pisa (samples B, C, G, J), Tuscany, Montepescali, Maremma
(42◦52′58.04” N/11◦05′11.97” E/42.882788◦ N) (samples D, E, F, H, I, K); Pistacia vera L.: Sicily, Mount
Etna (37◦45′04.45” N 14◦59′38.49” E) (sample M). Other essential oils were purchased: P. lentiscus
essential oil from Portugal (sample A) was obtained from Lifetree Aromatix, John Steel, 3949 Longridge
Ave. Sherman Oaks, CA, USA; P. integerrima J.L. Stewart ex Brandis essential oil was obtained from
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Bluebell Herbal Products, Bhaktapur, Nepal (samples N, O); P. lentiscus var. chia resin (mastic) essential
oil, was obtained from “Anemos” Benetos John Galatoulas George Co, Chios, Karfas RD, Kontari,
Chios, Greece (sample L).
Plant parts were recognized by one of the authors (G.I.), University of Padua, Italy. Voucher
specimens were deposited at the Department of Pharmaceutical and Pharmacological Sciences of the
University of Padova (PL01-11; PT01-17; PV01-1). Plant parts (leaves, berries, branches, flowers, galls
and nuts of P. lentiscus, P. terebinthus, and P. vera) were collected, rinsed, dried, and frozen at −21 ◦C
within three hours from collection to preserve their phytochemical composition until the moment of
the distillation. The material was then hydrodistilled within a few months. All the samples, before
distillation, were minced to obtain the maximum extraction yield and make the process of diffusion of
the essence easier [47–51].
3.3. Extraction of the Essential Oil
Plant parts were hydrodistilled with a Clevenger apparatus for 4 h. The oils were collected and
stored at 4 ◦C in sealed brown vials until analysis. The mean initial weights of the sample were: leaves
(450 g), branches, galls or nuts (250 g), berries (100 g), and flowers (270 g). The yield for the various
parts of the plant, express as percent of initial wet weight was: leaves (0.05%), branches (0.06%), nuts
(0.02%), berries (0.11%), flowers (0.08%), and galls (0.40%).
3.4. Phytochemical Determination of Essential Oil Constituents
The chemical composition of the essential oils obtained from P. lentiscus, P. terebinthus, P. vera,
P. integerrima, and P. lentiscus var. chia was determined by gas chromatography analysis coupled with
a mass spectrometer detector (GC/MS), with a Hewlett-Packard 6890-5973 system (Agilent Analytical
Instruments Littleton, CO, USA).
The identification of compounds by GC-MS was performed considering not only the matching of
mass spectra fragmentation but also the retention index. These two parameters allow the identification
of phytoconstituents of the essential oil. In particular, the separation was achieved using a HP-5
MS capillary column (30 m × 0.25 mm i.d. × 0.25 film thickness), with a stationary phase of
95%polydimethylsiloxane. GC-MS analysis carried out under the following conditions: carried
gas, He; flow rate, 0.8 mL/min; split ratio, 1:10; injection volume, 1 µL; injector temperature, 200 ◦C.
The temperature programme was as follows: 60 ◦C with 3 min initial hold, and then to 280 ◦C at a rate
of 3 ◦C/min, and finally held isothermally for 5 min. The ionization mode was electronic impact at 70
Ev. Identification of the components was achieved by comparison of their mass spectral fragmentation
patterns with those stored in the data bank (Wiley Library) [47–51]. The percentage composition of the
oil was calculated from GC peak areas using the normalization method without correction factors. The
data are reported as mean values of four oil injections.
3.5. Sample Preparation for Cell Assays
Pistacia oils were dissolved in DMSO and then diluted in culture medium to obtain stock solutions
which were stored at −20 ◦C. Each final stock solution contained 1% DMSO, 9% essential oil, and
90% culture medium. All the procedures were carried out under sterile conditions. Before each
experiment the stock solutions were diluted with growth medium and used immediately. The final
DMSO concentration was 1%.
3.6. Cell Lines
Cytotoxicity was evaluated on three human adenocarcinoma cell lines: ovarian (2008) breast
(MCF-7), and colon (LoVo). The cell line 2008 was kindly supplied by Prof. G. Marverti (Department
of Biomedical Sciences, University of Modena, Reggio Emilia, Italy) and was maintained in RPMI 1640
medium (Lonza, Basel, Switzerland). MCF-7 cells were supplied by the Experimental Zooprophylactic
Institute of Lombardy and Emilia (Brescia, Italy) and were grown in Eagle’s Minimum Essential
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Medium (Lonza, Basel, Switzerland). LoVo cells were supplied by Dr. G. Toffoli (Oncologic Reference
Centre, Aviano, Italy), and were grown in HAM’s F12 (Lonza). L929 fibroblasts (supplied by Lombardy
and Emilia Romagna Experimental Zootechnic Institute, Brescia, Italy) and HFFF2 cells, a human
Caucasian foetal foreskin fibroblast derived from a 14–18 old human foetus (ICLC cell bank, Genova,
Italy), were used as healthy controls to verify the specificity of the cytotoxic effects for cancer cells
(data not shown). L929 and HFFF2 cells were grown in RPMI 1640 medium (Lonza, Basel, Switzerland)
and in DMEM (Seromed-Biochrom KG, Berlin, Germany) respectively, and 1% penicillin/streptomycin
(10,000 U/10,000 µg/mL) (Seromed-Biochrom KG). All cultured media were supplemented with 10%
heat-inactivated FCS (foetal calf serum) (20% for HFFF2 cells), 1% antibiotics (100 U/mL penicillin and
100 µg/mL streptomycin) (Seromed-Biochrom KG), and 1% 200 mM glutamine (Merck, Darmstadt,
Germany). Cells were maintained under humidified conditions (air 95%; carbon dioxide (CO2) 5%, at
37 ◦C).
3.7. Cytotoxicity
Cells (1 × 105 cells/mL) were seeded in 96-well tissue plates (Falcon, New York, NY, USA) and
treated for 3 h with different concentrations of Pistacia essential oils, with single compounds, or with
vehicle (0.1% DMSO, untreated controls). The cells were then rinsed with sterile PBS and incubated
in culture medium for 21 h. The cytotoxic effect was evaluated by MTT reduction assay after 21 h
of incubation. An amount of 20 µL of MTT solution (5 mg/mL in PBS) was added to each well, and
plates were incubated for 4 h at 37 ◦C. DMSO (150 µL) was added to all wells and mixed thoroughly to
dissolve the dark-blue crystals. The absorbance was measured on a micro-culture plate reader (Titertek
Multiscan, Midland, ON, Canada) using a test wavelength of 570 nm and a reference wavelength of
630 nm. The 3 h pre-incubation followed by recovery model was chosen after some preliminary tests
aimed at identifying the best conditions to assay for specific cytotoxic effects. Cisplatin was used as the
positive control. IC50 values below 500 µg/mL were taken into consideration for the cytotoxic activity
of each phytocomplex tested. This value was chosen as threshold in line with recent literature on the
subject and other works on cytotoxicity of Pistacia essential oils, although some authors have used
different thresholds [30,43,44]. For each assay the experiments were performed at least three times and
each essential oil was tested in triplicate on the different cell lines.
3.8. Statistical Analysis
The results were statistically evaluated by Student’s t-test (two-tailed). IC50, dose-response curve
best-fit, Pearson correlation, and linear regression analysis were performed using GraphPad Prism
Version 3.0. Principal component analysis (PCA) was performed using XLSTAT® software (©Addinsoft
SARL, New York, NY, USA). PCA was performed on a correlation matrix (Pearson (n)), computed with
the contribution (%) of each compound to the IC50 of each oil sample, calculated with the following
formula: (
IC50
µg
ml
)
∗ compound %
100
Correlating the amount of each compound with the relative IC50 value takes into consideration
the intrinsic contribution of the compound to the cytotoxic effect of the phytocomplex and allows the
evaluation of its relative potency in the context of the phytocomplex. The resulting values were used
as variables in the matrix, and are the vectors in the biplot graphs of principal components, while the
samples of the different Pistacia species represent the observations in the matrix and the points in the
graph. The clusters of molecules in a given species were identified in the graphs according to four
vector characteristics: correlation with the Pistacia species, positive distribution with respect to one or
more given principal component, distance from the origin, and angle widths between vectors.
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4. Conclusions
This is the largest study conducted to investigate the in vitro anti-tumoral effect of different species
from the genus Pistacia. The phytocomplexes in essential oils from four different species of Pistacia
(lentiscus, terebinthus, vera, and integerrima) consistently, though differently, induced cytotoxicity on the
three cell lines of human adenocarcinoma, with variable potency and tropism depending on the species,
and no significant difference among samples from different aerial parts. In general, this suggests that
the in vitro anti-tumoral effect is a shared feature of the Pistacia genus, although there are differences
that also indicate patterns of activity characteristic for each species and for each adenocarcinoma.
PCA was used to investigate the correlations between the molecular components of the
phytocomplexes, most of them terpenes, sesquiterpenes, and fatty acids, and the observed biological
activity. This approach appears to be favourable because it takes into consideration the relative
contribution of each compound of the phytocomplex to the final effect on the tumoral cells creating
a correlation with the measured IC50 of the considered essential oils. Merging the chemical
composition data and the results of the biological assay by a multivariate approach offers a new
approach in the evaluation of the bioactivity of these complex mixture. This approach allows the
identification of clusters of compounds that, when present together in the mixture, are correlated with
increased bioactivity.
Molecular cooperation is the most important aspect of the biological activity found in natural
products, where a holistic approach is needed to understand their therapeutic potential. This was
confirmed in our PCA study and we found several clusters of bioactivity-associated molecules in each
species, likely to specifically synergize on each cell line. Two such clusters were shared for the three
adenocarcinomas, indicating the presence of at least two common pathways of cytotoxic activity, while
all the others were different, thus suggesting specific cell line sensitivity and different species-specific
mechanisms observed in vitro. Among the molecules identified only about 20% were compounds
already known for their anti-tumoral effect as single drugs, while the others were novel findings.
Among the new molecules identified, mostly terpenes, bornyl acetate showed significant cytotoxic
activity even when used alone, but to a much lesser extent if compared to the dose range present in
the essential oil, thus highlighting the importance of cooperation between different molecules in the
phytocomplex to achieve the final effect.
Acknowledgments: This work is dedicated to the memory of Maria Paola Belloni Regazzo, who, back in 1999
had the idea of looking into biological activities of Pistacia with the aim to identify new antitumoral strategies and
sustained and guided the team of scientists into the results presented here. This research was supported by private
grants from Data Medica Padova SpA. Part of this work was used for patent EP 1520585 A1, and U.S. Patent
Application No 10/676,101; DE602004032502D1; EP1520585B1; US20050074509; US20050163876, 2003 “Belloni,
M.P. Cancer Treatment Using Natural Plant Products or Essential Oils or Components from Some Pistacia Species”. Parts
of this work were presented in scientific meetings.
Author Contributions: A.B. and M.C. conceived and designed the experiments; A.B., S.D., M.M., D.G., and M.C.
performed the experiments; A.B., S.F., V.S., G.I., M.C. and S.D. analyzed the data; and A.B., S.F., V.S., S.D., G.I. and
M.C. wrote the paper.
Conflicts of Interest: Alessandro Buriani and Stefano Fortinguerra work as external collaborators for Data Medica,
but there is no conflict of interest, since the authors are not among the owners of the patent and do not share any
interest in the results other than their scientific value. The founding sponsors had no role in the design of the
study; in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to
publish the results.
References
1. Buriani, A.; Fortinguerra, S.; Carrara, M.; Pelkonen, O. Systems Network Pharmaco-Toxicology in the Study
of Herbal Medicines. In Toxicology of Herbal Products; Pelkonen, O., Duez, P., Vuorela, P.M., Vuorela, H., Eds.;
Springer: Cham, Switzerland, 2017; pp. 129–164.
2. Buriani, A.; Fortinguerra, S. The systems biology oriented, holistic vision of personalized medicine and the
emerging concept of proactive herbal medicine. Jacobs J. Intern Med. 2015, 1, 007.
Molecules 2017, 22, 1336 18 of 20
3. Buriani, A.; Garcia-Bermejo, M.L.; Bosisio, E.; Xu, Q.; Li, H.; Dong, X.; Simmonds, M.S.; Carrara, M.;
Tejedor, N.; Lucio-Cazana, J.; et al. Omic techniques in systems biology approaches to traditional Chinese
medicine research: present and future. J. Ethnopharmacol. 2012, 140, 535–544. [CrossRef] [PubMed]
4. Bilecová-Rabajdová, M.; Birková, A.; Urban, P.; Gregová, K.; Durovcová, E.; Mareková, M. Naturally
occurring substances and their role in chemo-protective effects. Cent. Eur. J. Public Health 2013, 21, 213–219.
[PubMed]
5. Crowell, P.L. Prevention and therapy of cancer by dietary monoterpenes. J. Nutr. 1999, 129, 775S–778S.
[PubMed]
6. Morgan-Meadows, S.; Dubey, S.; Gould, M.; Tutsch, K.; Marnocha, R.; Arzoomanin, R.; Alberti, D.; Binger, K.;
Feierabend, C.; Volkman, J.; et al. Phase I trial of perillyl alcohol administered four times daily continuously.
Cancer Chemother. Pharmacol. 2003, 52, 361–366. [CrossRef] [PubMed]
7. Bozorgi, M.; Memariani, Z.; Mobli, M.; Salehi Surmaghi, M.H.; Shams-Ardekani, M.R.; Rahimi, R. Five
Pistacia. species (P. vera, P. atlantica, P. terebinthus, P. khinjuk, and P. lentiscus): A review of their traditional
uses, phytochemistry, and pharmacology. Sci. World J. 2013, 15, e219815.
8. Lesgards, J.F.; Baldovini, N.; Vidal, N.; Pietri, S. Anticancer activities of essential oils constituents and synergy
with conventional therapies: A review. Phytother. Res. 2014, 28, 1423–1446. [CrossRef] [PubMed]
9. Bayala, B.; Bassole, I.H.N.; Scifo, R.; Gnoula, C.; Morel, L.; Lobaccaro, J.M.A.; Simpore, J. Anticancer activity
of essential oils and their chemical components—A review. Am. J. Cancer Res. 2014, 4, 591–607. [PubMed]
10. Homburger, F.; Treger, A.; Boger, E. Inhibition of murine subcutaneous and intravenous benzo (rst)
pentaphene. Carcinogenesis by sweet orange oils and d-limonene. Oncology 1971, 25, 1–10. [CrossRef]
[PubMed]
11. Wattenberg, L.W.; Coccia, J.B. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone carcinogenesis
in mice by D-limonene and citrus fruit oils. Carcinogenesis 1991, 12, 115–117. [CrossRef] [PubMed]
12. Haag, J.D.; Lindstrom, M.J.; Gould, M.N. Limonene-induced regression of mammary carcinomas. Cancer Res.
1992, 15, 4021–4026.
13. Gould, M.N.; Moore, C.J.; Zhang, R.; Wang, B.; Kennan, W.S.; Haag, J.D. Limonene chemoprevention of
mammary carcinoma induction following direct in situ transfer of v-Ha-ras. Cancer Res. 1994, 54, 3540–3543.
[PubMed]
14. Lu, X.G.; Zhan, L.B.; Feng, B.A.; Qu, M.Y.; Yu, L.H.; Xie, J.H. Inhibition of growth and metastasis of human
gastric cancer implanted in nude mice by d-limonene. World J. Gastroenterol. 2004, 10, 2140–2144. [CrossRef]
[PubMed]
15. Sobral, M.V.; Xavier, A.L.; Lima, T.C.; de Sousa, D.; Pergentino, O. Antitumor activity of monoterpenes found
in essential oils. Sci. World J. 2014, 2014, e953451. [CrossRef] [PubMed]
16. Carnesecchi, S.; Bras-Gonçalves, R.; Bradaia, A.; Zeisel, M.; Gossé, F.; Poupon, M.F.; Raul, F. Geraniol, a
component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on
human colon tumor xenografts. Cancer Lett. 2004, 215, 53–59. [CrossRef] [PubMed]
17. Lampronti, I.; Saab, A.M.; Gambari, R. Antiproliferative activity of essential oils derived from plants
belonging to the Magnoliophyta division. Int. J. Oncol. 2006, 29, 989–995. [CrossRef] [PubMed]
18. Legault, J.; Pichette, A. Potentiating effect of beta-caryophyllene on anticancer activity of alpha-humulene,
isocaryophyllene and paclitaxel. J. Pharm. Pharmacol. 2007, 59, 1643–1647. [CrossRef] [PubMed]
19. Pal, D.; Banerjee, S.; Mukherjee, S.; Roy, A.; Panda, C.K.; Das, S. Eugenol restricts DMBA croton oil induced
skin carcinogenesis in mice: Downregulation of c-Myc and H-ras, and activation of p53 dependent apoptotic
pathway. J. Dermatol. Sci. 2010, 59, 31–39. [CrossRef] [PubMed]
20. Cardozo, M.T.; de Conti, A.; Ong, T.P.; Scolastici, C.; Purgatto, E.; Horst, M.A.; Bassoli, B.K.; Moreno, F.S.
Chemopreventive effects of β-ionone and geraniol during rat hepatocarcinogenesis promotion: Distinct
actions on cell proliferation, apoptosis, HMGCoA reductase, and RhoA. J. Nutr. Biochem. 2011, 22, 130–135.
[CrossRef] [PubMed]
21. Satooka, H.; Kubo, I. Effects of thymol on B16-F10 melanoma cells. J. Agric. Food Chem. 2012, 60, 2746–2752.
[CrossRef] [PubMed]
22. Al-Saghir, M.G.; Porter, D.M. Taxonomic Revision of the Genus Pistacia L. (Anacardiaceae). AJPS 2012, 3,
12–32. [CrossRef]
23. Zohara, Y.; Nativ, D. Medicinal and Aromatic Plants of the Middle-East; Springer: Cham, Switzerland, 2014.
Molecules 2017, 22, 1336 19 of 20
24. Loutrari, H.; Magkouta, S.; Pyriochou, A.; Koika, V.; Kolisis, F.N.; Papapetropoulos, A.; Roussos, C.;
Roussos, C. Mastic oil from Pistacia lentiscus var. chia inhibits growth and survival of human K562 leukemia
cells and attenuates angiogenesis. Nutr. Cancer 2006, 55, 86–93. [CrossRef] [PubMed]
25. Balan, K.V.; Prince, J.; Han, Z.; Dimas, K.; Cladaras, M.; Wyche, J.H.; Sitaras, N.M.; Pantazis, P.; Pantazis, P.
Antiproliferative activity and induction of apoptosis in human colon cancer cells treated in vitro with
constituents of a product derived from Pistacia lentiscus L. var. chia. Phytomedicine 2007, 14, 263–272.
[CrossRef] [PubMed]
26. Loutrari, H.; Magkouta, S.; Papapetropoulos, A.; Roussos, C. Mastic oil inhibits the metastatic phenotype of
mouse lung adenocarcinoma cells. Cancers 2011, 3, 789–801. [CrossRef] [PubMed]
27. Giaginis, C.; Theocharis, S. Current evidence on the anticancer potential of Chios mastic gum. Nutr. Cancer
2011, 63, 1174–1184. [CrossRef] [PubMed]
28. Morad, S.A.; Schmidt, C.; Büchele, B.; Schneider, B.; Wenzler, M.; Syrovets, T.; Simmet, T.; Simmet, T.
(8R)-3β,8-Dihydroxypolypoda-13E,17E,21-triene induces cell cycle arrest and apoptosis in treatment-resistant
prostate cancer cells. J. Nat. Prod. 2011, 74, 1731–1736. [CrossRef] [PubMed]
29. Dimas, K.; Hatziantoniou, S.; Wyche, J.H.; Pantazis, P. A mastic gum extract induces suppression of growth
of human colorectal tumor xenografts in immunodeficient mice. In Vivo 2009, 23, 63–68. [PubMed]
30. Catalani, S.; Palma, F.; Battistelli, S.; Benedetti, S. Oxidative stress and apoptosis induction in human thyroid
carcinoma cells exposed to the essential oil from Pistacia lentiscus aerial parts. PLoS ONE 2017, 12, e0172138.
[CrossRef] [PubMed]
31. Spyridopoulou, K.; Tiptiri-Kourpeti, A.; Lampri, E.; Fitsiou, E.; Vasileiadis, S.; Vamvakias, M.; Bardouki, H.;
Goussia, A.; Malamou-Mitsi, V.; Panayiotidis, M.I.; et al. Dietary mastic oil extracted from Pistacia lentiscus
var. chia suppresses tumor growth in experimental colon cancer models. Sci. Rep. 2017, 7, 3782. [CrossRef]
[PubMed]
32. Almehdar, H.; Abdallah, H.M.; Osman, A.M.M.; Abdel-Sattar, E.A. In vitro cytotoxic screening of selected
Saudi medicinal plants. J. Nat. Med. 2012, 66, 406–412. [CrossRef] [PubMed]
33. Bibi, Y.; Nisa, S.; Zia, M.; Waheed, A.; Ahmed, S.; Chaudhary, M.F. The study of anticancer and antifungal
activities of Pistacia integerrima extract in vitro. Indian J. Pharm. Sci. 2012, 74, 375–379. [PubMed]
34. Rezaei, P.F.; Fouladdel, S.; Hassani, S.; Yousefbeyk, F.; Ghaffari, S.M.; Amin, G.; Ebrahim, A.; Ebrahim, A.
Induction of apoptosis and cell cycle arrest by pericarp polyphenol-rich extract of Baneh in human colon
carcinoma HT29 cells. Food Chem. Toxicol. 2012, 50, 1054–1059. [CrossRef] [PubMed]
35. Fathalizadeh, J.; Bagheri, V.; Khorramdelazad, H.; Kazemi Arababadi, M.; Jafarzadeh, A.; Mirzaei, M.R.;
Shamsizadeh, A.; Hajizadeh, M.R. Induction of apoptosis by pistachio (Pistacia vera L.) hull extract and its
molecular mechanisms of action in human hepatoma cell line HepG2. Cell. Mol. Biol. 2015, 61, 128–134.
[PubMed]
36. Mirian, M.; Behrooeian, M.; Ghanadian, M.; Dana, N.; Sadeghi-Aliabadi, H. Cytotoxicity and antiangiogenic
effects of Rhus coriaria, Pistacia vera and Pistacia khinjuk oleoresin methanol extracts. Res. Pharm. Sci. 2015, 10,
233–240. [PubMed]
37. Mezni, F.; Shili, S.; Ben Ali, N.; Larbi Khouja, M.; Khaldi, A.; Maaroufi, A. Evaluation of Pistacia lentiscus seed
oil and phenolic compounds for in vitro antiproliferative effects against BHK21 cells. Pharm. Biol. 2016, 54,
747–751. [CrossRef] [PubMed]
38. Piccolella, S.; Nocera, P.; Carillo, P.; Woodrow, P.; Greco, V.; Manti, L.; Fiorentino, A.; Pacifico, S. An apolar
Pistacia lentiscus L. leaf extract: GC-MS metabolic profiling and evaluation of cytotoxicity and apoptosis
inducing effects on SH-SY5Y and SK-N-BE(2)C cell lines. Food Chem. Toxicol. 2016, 95, 64–74. [CrossRef]
[PubMed]
39. Loizzo, M.R.; Tundis, R.; Menichini, F.; Saab, A.M.; Statti, G.A.; Menichini, F. Cytotoxic activity of essential
oils from labiatae and lauraceae families against in vitro human tumor models. Anticancer Res. 2007, 27,
3293–3299. [PubMed]
40. Da Silva, J.K.; Da Trindade, R.; Moreira, E.C.; Maia, J.G.S.; Dosoky, N.S.; Miller, R.S.; Cseke, L.J.; Setzer, W.N.
Chemical Diversity, Biological Activity, and GeneticAspects of Three Ocotea Species from the Amazon. Nat.
Prod. Commun. 2013, 8, 1481–1486.
41. Paudel, P.; Satyal, P.; Dosoky, N.S.; Maharjan, S.; Setzer, W.N. Juglans regia and J. nigra, two trees important in
traditional medicine: A comparison of leaf essential oil compositions and biological activities. Int. J. Mol. Sci.
2017, 18, 1081.
Molecules 2017, 22, 1336 20 of 20
42. Kaneda, N.; Pezzuto, J.M.; Kinghorn, A.D.; Farnsworth, N.R.; Santisuk, T.; Tuchinda, P.; Udchachon, J.;
Reutrakul, V. Plant anticancer agents, L. cytotoxic triterpenes from Sandoricum koetjape stems. J. Nat. Prod.
1992, 55, 654–659. [PubMed]
43. Graidist, P.; Martla, M.; Sukpondma, Y. Cytotoxic activity of Piper cubeba extract in breast cancer cell lines.
Nutrients 2015, 10, 2707–2718. [CrossRef] [PubMed]
44. Russo, R.; Corasaniti, M.T.; Bagetta, G.; Morrone, L.A. Exploitation of cytotoxicity of some essential oils for
translation in cancer therapy. Evid. Based Complement. Altern. Med. 2015, 2015, 397821. [CrossRef] [PubMed]
45. Owolabi, M.S.; Ogundajo, A.L.; Dosoky, N.S.; Setzer, W.N. The cytotoxic activity of annona muricata leaf oil
from badagary, Nigeria. Am. J. Essent. Oil Nat. Prod. 2013, 1, 1–3.
46. Shapira, S.; Pleban, S.; Kazanov, D.; Tirosh, P.; Arber, N. Terpinen-4-ol: A novel and promising therapeutic
agent for human gastrointestinal cancers. PLoS ONE 2016, 11, e0156540. [CrossRef] [PubMed]
47. Boelens, M.H.; Jimenez, R. Chemical composition of the essential oils from the gum and from various parts
of Pistacia lentiscus L. (mastic gum tree). Flavour Fragr. J. 1991, 6, 271–275. [CrossRef]
48. De Pooter, H.L.; Schamp, N.M.; Aboutabl, E.A.; El Tohamy, S.F.; Doss, S.L. Essential oils from the leaves of
three Pistacia species grown in Egypt. Flavour Fragr. J. 1991, 6, 229–232. [CrossRef]
49. Magiatis, P.; Melliou, E.; Skaltsounis, A.L.; Chinou, I.B.; Mitaku, S. Chemical composition and antimicrobial
activity of the essential oils of Pistacia lentiscus var. chia. Planta Med. 1999, 65, 749–752. [CrossRef] [PubMed]
50. Papageorgiou, V.P.; Argyriadou, N. Trace constituents in the essential oil of Thymus capitatus. Phytochemistry
1981, 20, 2295–2297. [CrossRef]
51. Gardeli, C.; Vassiliki, P.; Athanasios, M.; Kibouris, T.; Komaitis, M. Essential oil composition of Pistacia
lentiscus L. and Myrtus communis L.: Evaluation of antioxidant capacity of methanolic extracts. Food Chem.
2008, 107, 1120–1130. [CrossRef]
Sample Availability: Samples of essential oils can be available from the authors.
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
